These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Hallock RM; Dean A; Knecht ZA; Spencer J; Taverna EC Drug Alcohol Depend; 2013 Jun; 130(1-3):245-8. PubMed ID: 23265089 [TBL] [Abstract][Full Text] [Related]
35. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Barrett FS; Carbonaro TM; Hurwitz E; Johnson MW; Griffiths RR Psychopharmacology (Berl); 2018 Oct; 235(10):2915-2927. PubMed ID: 30062577 [TBL] [Abstract][Full Text] [Related]
36. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Cavanna F; Muller S; de la Fuente LA; Zamberlan F; Palmucci M; Janeckova L; Kuchar M; Pallavicini C; Tagliazucchi E Transl Psychiatry; 2022 Aug; 12(1):307. PubMed ID: 35918311 [TBL] [Abstract][Full Text] [Related]
37. Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Gouzoulis-Mayfrank E; Schreckenberger M; Sabri O; Arning C; Thelen B; Spitzer M; Kovar KA; Hermle L; Büll U; Sass H Neuropsychopharmacology; 1999 Jun; 20(6):565-81. PubMed ID: 10327426 [TBL] [Abstract][Full Text] [Related]
38. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Griffiths RR; Johnson MW; Richards WA; Richards BD; Jesse R; MacLean KA; Barrett FS; Cosimano MP; Klinedinst MA J Psychopharmacol; 2018 Jan; 32(1):49-69. PubMed ID: 29020861 [TBL] [Abstract][Full Text] [Related]
39. Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. Carter OL; Hasler F; Pettigrew JD; Wallis GM; Liu GB; Vollenweider FX Psychopharmacology (Berl); 2007 Dec; 195(3):415-24. PubMed ID: 17874073 [TBL] [Abstract][Full Text] [Related]
40. Effects of psilocybin on time perception and temporal control of behaviour in humans. Wittmann M; Carter O; Hasler F; Cahn BR; Grimberg U; Spring P; Hell D; Flohr H; Vollenweider FX J Psychopharmacol; 2007 Jan; 21(1):50-64. PubMed ID: 16714323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]